- Anti-tumor immunity and immunotherapy2017 | Second Faculty of Medicine
- Betulinines with anti-tumor activity with the wide spectrum of efficiency2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Preparation of lupane triterpenoids with anti-tumor activity.Publication without faculty affiliation
- Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry2013 | Faculty of Pharmacy in Hradec Králové
- The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease2020 | Second Faculty of Medicine
- Advanced prostate cancer and anti-tumor chemotherapy2003 | First Faculty of Medicine
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | First Faculty of Medicine
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | Faculty of Physical Education and Sport
- Betulinines with anti-tumor activity with the wide spectrum of efficiency2003 | Faculty of Science
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-122005 | First Faculty of Medicine
- Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-122005 | Faculty of Physical Education and Sport
- SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity2022 | Second Faculty of Medicine
- Deep vein thrombosis and lung cancer in a patient with psoriasis under anti-tumor necrosis factor treatment: a case study2014 | Faculty of Medicine in Pilsen
- Cytochrome P450-and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency2011 | Faculty of Science
- Anti-tumor and immunomobilizing activity of PHPMA-bound drugs: preclinical and clinical evaluation.Publication without faculty affiliation
- Psychological and psychosocial intervention in oncological patients - its importance and position in anti-tumorous therapy in view of the oncologist +12009 | Faculty of Medicine in Hradec Králové
- Psychological and psychosocial intervention in oncological patients - its importance and position in anti-tumorous therapy in view of the oncologist2009 | First Faculty of Medicine
- Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents2015 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Psychological and psychosocial intervention in oncological and haematooncological patients its importance and position in anti-tumorous therapy in view of the oncologist2008 | Faculty of Medicine in Hradec Králové
- Psychological and psychosocial intervention in oncological and haematooncological patients its importance and position in anti-tumorous therapy in view of the oncologist2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin inuduces anti-tumor immunityPublication without faculty affiliation
- Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn´s disease: the CLASSIC-I trial2006 | First Faculty of Medicine
- Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn´s disease: the CLASSIC-I trial2006 | Faculty of Physical Education and Sport
- Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation2016 | First Faculty of Medicine, Second Faculty of Medicine
- Psychological and psychosocial intervention in oncological and haematooncological patients its importance and position in anti-tumorous therapy in view of the oncologist2008 | First Faculty of Medicine